Dibucaine Hydrochloride - CAS 61-12-1
Catalog number:
61-12-1
Category:
Inhibitor
Not Intended for Therapeutic Use. For research use only.
Molecular Formula:
C20H29N3O2.HCl
Molecular Weight:
379.92
COA:
Inquire
Targets:
Sodium Channel
Description:
Dibucaine HCl is a local anesthetics.Among the most potent and toxic of the long-acting local anesthetics, current use of it is generally restricted to spinal and topical anesthesia.
Publictions citing BOC Sciences Products
  • >> More
Purity:
>98%
Synonyms:
Cinchocaine HCl
MSDS:
Inquire
1.Preparation and properties of carrageenan microspheres containing allopurinol and local anesthetic agents for the treatment of oral mucositis.
Tomoda K1, Asahiyama M, Ohtsuki E, Nakajima T, Terada H, Kanebako M, Inagi T, Makino K. Colloids Surf B Biointerfaces. 2009 Jun 1;71(1):27-35. doi: 10.1016/j.colsurfb.2009.01.003. Epub 2009 Jan 9.
For the treatment of oral mucositis, carrageenan microspheres containing allopurinol and local anesthetic agents, such as lidocaine hydrochloride, dibucaine hydrochloride and tetracaine hydrochloride were prepared using a spray-drying method. As base materials, kappa-carrageenan and iota-carrageenan were evaluated, since carrageenan mitigates bitter taste of lidocaine hydrochloride, dibucaine hydrochloride and tetracaine hydrochloride. The microspheres were spherical and their average diameters were about 10 microm. The drug loading efficiency was more than 70%. Allopurinol and local anesthetic agents became amorphous by the spray drying. Allopurinol and the local anesthetic agents were released from the microspheres for at least 400 min when iota-carrageenan was used as a base material. On the other hand, the release was prolonged to 600 min when kappa-carrageenan was used. The microspheres were spread and made membranes at the air/water interfaces immediately after dropped on the water surfaces.
2.Aerosol OT microemulsions as carriers for transdermal delivery of hydrophobic and hydrophilic local anesthetics.
Junyaprasert VB1, Boonme P, Wurster DE, Rades T. Drug Deliv. 2008 Jun;15(5):323-30. doi: 10.1080/10717540802035319 .
The skin permeation enhancement of many kinds of drugs and cosmetic substances by microemulsions has been widely known; however, the correlations between microemulsion microstructures and the efficiency of skin permeation are not fully elucidated. Therefore, the aim of our study was to investigate the influence of microemulsion types on in vitro skin permeation of model hydrophobic drugs and their hydrophilic salts. The microemulsion systems were composed of isopropyl palmitate (IPP), water, a 2:1 w/w mixture of Aerosol OT (AOT) and 1-butanol, and a model drug. The concentrations of surfactant mixture and model drug were maintained at 45% and 1% w/w, respectively. The concentrations of IPP and water were 15% and 39% w/w, respectively, for oil-in-water (o/w) type and vice versa for water-in-oil (w/o) type. The samples were prepared by simple mixing and characterized by visual appearance, pH, refractive index, electrical conductivity, viscosity, and determination of the state of water and IPP in the formulations using differential scanning calorimetry.
3.Wetting of surfactant solutions by alkanes.
Wilkinson KM1, Bain CD, Matsubara H, Aratono M. Chemphyschem. 2005 Mar;6(3):547-55.
Ellipsometry, surface tensiometry, and contact-angle measurement have been used to study the transition between partial wetting and pseudo-partial wetting of surfactant solutions by alkanes. In the partial wetting regime, the air-water surface tension is the same with and without alkane. In the pseudo-partial wetting regime, the air-water surface tension is lowered by the presence of alkane, showing that oil is solubilised into the surfactant monolayer. A discontinuous change in the coefficient of ellipticity with increasing surfactant concentration provides unequivocal evidence for the first-order nature of the wetting transitions. Ellipsometry has been used to explore the generality of wetting transitions of alkanes (dodecane, hexadecane, and squalane) on surfactant solutions [dodecyltrimethylammonium bromide, tetredecyltrimethylammonium bromide, dibucaine hydrochloride, and Aerosol OT (AOT)]. Of the systems studied, only hexadecane on AOT solutions did not show a wetting transition.
4.[Ionic strength influences hemolytic action of dibucaine hydrochloride].
Katsuki H1, Tateyama S, Hidaka N, Takasaki M. Masui. 2003 Nov;52(11):1174-80.
BACKGROUND: Little is known about effect of ionic strength on local anesthetic toxicity. Using human erythrocytes, hemolytic action of dibucaine in solutions of various ionic strength was investigated.
Molecular Weight Calculator Molarity Calculator Solution Dilution Calculator

Related Sodium Channel Products


CAS 934240-30-9 Raxatrigine

Raxatrigine
(CAS: 934240-30-9)

Raxatrigine is a novel analgesic for the treatment of lumbosacral radiculopathy (sciatica) and trigeminal neuralgia. It acts as a selective, small-molecule, sta...

GS967
(CAS: 1262618-39-2)

GS967, also known as GS-458967, is a highly selective late sodium channel current blocker. The selective inhibition of late INa with GS967 can exert antiarrhyth...

CAS 298-46-4 Carbamazepine

Carbamazepine
(CAS: 298-46-4)

Carbamazepine (Carbatrol) is a sodium channel blocker with IC50 of 131 μM in rat brain synaptosomes.Carbamazepine (CBZ), first marketed under the tradename Tegr...

CAS 42971-09-5 Vinpocetine

Vinpocetine
(CAS: 42971-09-5)

Vinpocetine is a Phosphodiesterase inhibitor and selective for PDE1. It also blocks voltage-gated Na+ channels.

Nav1.7-IN-2
(CAS: 1332295-35-8)

Nav1.7-IN-2, a voltage-gated sodium channels, could be probably effective in chronic pain therapy. IC50: 80 nM.

CAS 34183-22-7 Propafenone hydrochloride

Propafenone hydrochloride
(CAS: 34183-22-7)

Propafenone is a Class 1C antiarrhythmic as sodium channel blocker by slowing the influx of sodium ions into the cardiac muscle cells.

PD 122860
(CAS: 122576-86-7)

This active molecular is a calcium channel antagonist with sodium channel stimulating property as a dihydropyridine. PD 122860 can increase left ventricular con...

CAS 892546-37-1 PH-064

PH-064
(CAS: 892546-37-1)

PH-064 is a sodium channel inhibitor. It is extracted from patent FR 2879460 A1.

CAS 95635-55-5 Ranolazine

Ranolazine
(CAS: 95635-55-5)

Ranolazine is a calcium uptake inhibitor via the sodium/calcium channal, used to treat chronic angina.

CAS 50-12-4 Mephenytoin

Mephenytoin
(CAS: 50-12-4)

Mephenytoin is known to target sodium channel protein type 5 subunit alpha. It is a hydantoin-derivative anticonvulsant used to control various partial seizures...

CAS 132112-35-7 Ropivacaine Hydrochloride

Ropivacaine Hydrochloride
(CAS: 132112-35-7)

Ropivacaine hydrochloride is an anaesthetic agent and blocks impulse conduction in nerve fibres through inhibiting sodium ion influx reversibly.

CAS 4368-28-9 Tetrodotoxin

Tetrodotoxin
(CAS: 4368-28-9)

Tetrodotoxin, frequently abbreviated as TTX, is a potent neurotoxin. Its name derives from Tetraodontiformes, an order that includes pufferfish, porcupinefish, ...

CAS 944261-79-4 A-803467

A-803467
(CAS: 944261-79-4)

A-803467 is a sodium channel blocker that potently blocks tetrodotoxin-resistant currents (IC50=140 nM).

ICA-121431
(CAS: 313254-51-2)

ICA-121431 is a potent and selective inhibitor of human NaV1.3 (IC50=13 nM) and NaV1.1 channels (IC50=23 nM) with 1,000 fold selectivity against other resistant...

PF-05089771
(CAS: 1235403-62-9)

PF-05089771, a Nav1.7 channel blocker, has been studied to have potential effect in the treatment of chronic neuropathic pain. It is still under Phase II clinic...

AM-36
(CAS: 199467-52-2)

AM-36 is a potent blocker of batrachotoxinin (BTX)-sensitive Na+ channel binding in rat brain homogenates with an IC50 of 0.28 microM. As a unique neuroprotecti...

CAS 536-43-6 Dyclonine Hydrochloride

Dyclonine Hydrochloride
(CAS: 536-43-6)

Dyclonine HCl is a hydrochloride salt form of dyclonine which is an oral anaesthetic.

PF-04856264
(CAS: 1235397-05-3)

This active molecular is a human Nav1.7 voltage gated sodium channel inhibitor with the IC50 value of 28 nM. PF-04856264 inhibits the Nav channel by interacting...

CAS 1744-22-5 Riluzole

Riluzole
(CAS: 1744-22-5)

Riluzole is a drug used to treat amyotrophic lateral sclerosis.

CAS 28721-07-5 Oxcarbazepine

Oxcarbazepine
(CAS: 28721-07-5)

Oxcarbazepine inhibits the binding of [3H]BTX to sodium channels with IC50 of 160 μM and also inhibits the influx of 22Na+ into rat brain synaptosomes with IC50...

Chemical Structure

CAS 61-12-1 Dibucaine Hydrochloride

Quick Inquiry

Verification code

Featured Items